Mar 12 |
Longboard Pharmaceuticals files for mixed shelf offering
|
Mar 12 |
Longboard Pharmaceuticals GAAP EPS of -$2.39 beats by $0.02
|
Mar 12 |
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
|
Feb 16 |
Longboard stock up 8% as Citi initiates at buy, citing takeover potential
|
Feb 2 |
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
|
Feb 1 |
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February
|
Jan 19 |
Looking Into Longboard Pharmaceuticals's Recent Short Interest
|
Jan 17 |
Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher
|
Jan 8 |
Longboard Pharmaceuticals raises ~$241.5M through public offering of shares
|
Jan 8 |
Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
|